SCHEMBL25150378

SCHEMBL25150378

CCCCCCC(CCCCC)c1ccnc(C)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
UHRF1 Q96T88 1/20 0.38
NR1I2 O75469 1/20 0.38
PSEN1 P49768 2/20 0.36
PSEN2 P49810 2/20 0.36
APH1B Q8WW43 2/20 0.36
NCSTN Q92542 2/20 0.36
APH1A Q96BI3 2/20 0.36
PSENEN Q9NZ42 2/20 0.36
SLC2A1 P11166 1/20 0.36
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
ADA P00813 2/20 0.33
TBXAS1 P24557 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
BDKRB2 P30411 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18879378 0.85 KDM4E (0.38) UHRF1NR1I2PSEN1PSEN2APH1B
SCHEMBL174988 0.85 NR1I2 (0.39) NR1I2SLC2A1KDM4EHPGDGPR84
SCHEMBL22298879 0.83 UHRF1 (0.38) UHRF1NR1I2PSEN1PSEN2APH1B
SCHEMBL22260475 0.82 NR1I2 (0.37) NR1I2SLC2A1KDM4EHPGDGPR84
SCHEMBL22458264 0.82 NR1I2 (0.37) NR1I2SLC2A1KDM4EHPGDGPR84
SCHEMBL3443825 0.82 AR (0.38) NR1I2SLC2A1KDM4EHPGDGPR84
SCHEMBL3443064 0.82 NOS3 (0.43) NR1I2SLC2A1KDM4EGPR84ADA
SCHEMBL18672331 0.81 NOS3 (0.42) NR1I2SLC2A1KDM4EGPR84ADA
SCHEMBL27345654 0.81 KCNH2 (0.42) NR1I2SLC2A1KDM4EGPR84
SCHEMBL19185480 0.81 NOS3 (0.42) NR1I2SLC2A1KDM4EGPR84ADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 UHRF1 4352/4885NR1I2 177/4885PSEN1 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.